[144] Delek Logistics Partners, LP SEC Filing

Rhea-AI Filing Summary

This Form 144 notice reports a proposed sale of 250 common shares of Delek Logistics Partners, LP (DKL) to be executed through Fidelity Brokerage Services LLC on 09/12/2025 on the NYSE for an aggregate market value of $11,250. The filer acquired those 250 shares by restricted stock vesting (73 shares on 06/10/2022 and 177 shares on 09/10/2022) and lists 53,463,829 shares outstanding. The filing also discloses prior open-market sales by the same person during the past three months: 500 shares on 07/29/2025 for $22,500 and 250 shares on 08/04/2025 for $11,250. The signer represents they know of no undisclosed material adverse information about the issuer.

Positive

• Complete transaction details provided: number of shares, acquisition dates, broker, proposed sale date, and aggregate market value are all disclosed
• Acquisition method disclosed: shares were acquired via restricted stock vesting, indicating compensation origin
• Prior sales reported: two recent open-market sales (500 and 250 shares) are listed, aiding transparency

Negative

• Insider disposals recently reported: the filer sold 500 shares on 07/29/2025 and 250 shares on 08/04/2025, totaling 750 shares in the prior three months
• Limited context on market impact: filing includes raw sale amounts and values but provides no explanation of rationale for sales

Insights

Securities Compliance Analyst

TL;DR: Disclosure documents a Rule 144 sale via broker and recent insider sales; appears to follow required reporting elements.

The Form 144 provides the required transaction-level details: number of shares to be sold (250), acquisition dates and nature (restricted stock vesting), broker identity (Fidelity Brokerage Services LLC), proposed sale date (09/12/2025), and aggregate market value ($11,250). It also lists prior sales in the last three months, which helps determine aggregation and volume limits under Rule 144. The filer makes the standard representation about lack of undisclosed material adverse information. From a compliance standpoint, the filing contains the core fields necessary for a Rule 144 notice.

Equity Markets Analyst

TL;DR: The notice records modest planned and recent disposals of common shares; transaction details are transparently reported.

The document shows a planned sale of 250 common shares and two prior sales totaling 750 shares in the preceding months, with explicit prices and dates. Acquisition records indicate the shares were received as compensation via restricted stock vesting in 2022. The filing names the executing broker and the exchange (NYSE), which provides market context for execution. The data are factual and permit straightforward tracking of the insider's reported dispositions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	250	11250.00	53463829	09/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/10/2022	Restricted Stock Vesting	Issuer			73	06/10/2022	Compensation
Common	09/10/2022	Restricted Stock Vesting	Issuer			177	09/10/2022	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Reuven Spiegel 310 Seven Springs Way Suite 500 Brentwood TN 37027	Common	07/29/2025	500	22500.00
Reuven Spiegel 310 Seven Springs Way Suite 500 Brentwood TN 37027	Common	08/04/2025	250	11250.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does this Form 144 for DKL report?

The filing reports a proposed sale of 250 common shares of DKL via Fidelity on 09/12/2025 with aggregate market value of $11,250.

How were the 250 shares being sold acquired?

The 250 shares were acquired by restricted stock vesting: 73 shares on 06/10/2022 and 177 shares on 09/10/2022.

Has the filer sold other DKL shares recently?

Yes. The filer sold 500 shares on 07/29/2025 for $22,500 and 250 shares on 08/04/2025 for $11,250.

Through which broker and exchange will the proposed sale occur?

The sale is to be executed through Fidelity Brokerage Services LLC on the NYSE.

Does the filer attest to any undisclosed material information?

The filer represents by signature that they do not know any material adverse information about the issuer that has not been publicly disclosed.